Results 161 to 170 of about 120,820 (237)

Extensive longitudinal lupic myelitis: A case report with a literature review. [PDF]

Radiol Case Rep
Guennouni A, Harras YE, El Bougrini Z, Laridi A, Sahel N, Abourak C, En-Nouali H, El Fenni J, Sekkach Y.   +8 more
europepmc   +1 more source

Systemic Lupus Erythematosus [PDF]

Canadian Psychiatric Association Journal, 1972
openaire   +2 more sources

The Aetiology of Elevated Total Serum Immunoglobulin E in Children

Acta Paediatrica, EarlyView.
ABSTRACT Aim The paucity of real‐world data on the aetiology of elevated total serum immunoglobulin E (TS‐IgE) in children afflicts families and health care systems with diagnostic uncertainty. We explored a cohort of children with TS‐IgE levels over 1000 kU/L, focusing on the prevalence of atopic and non‐atopic conditions, the aetiology of extremely ...
Aliisa Ärölä, Kaarina Kukkonen, Svetlana Vakkilainen   +2 more
wiley   +1 more source

Expression pattern and clinical significance of MerTK on circulating NK cells in systemic lupus erythematosus. [PDF]

Lupus Sci Med
Liang R, Yao R, Wang Z, Pei W, Liang R, Han X, Xu H, Zhu Y, Guo J, Su Y.   +9 more
europepmc   +1 more source

The role of B cell-activating factor system in autoimmune diseases: mechanisms, disease implications, and therapeutic advances. [PDF]

Front Immunol
Li L, Shen S, Shao S, Dang E, Wang G, Fang H, Qiao H.   +6 more
europepmc   +1 more source

Non‐canonical nitric oxide signalling and DNA methylation: Inflammation induced epigenetic alterations and potential drug targets

British Journal of Pharmacology, EarlyView.
Abstract DNA methylation controls DNA accessibility to transcription factors and other regulatory proteins, thereby affecting gene expression and hence cellular identity and function. As epigenetic modifications control the transcriptome, epigenetic dysfunction is strongly associated with pathological conditions and ageing.
Christopher H. Switzer
wiley   +1 more source

Ophthalmic Posterior Segment OCTA Metrics as Potential Biomarkers for Systemic Involvement in Systemic Sclerosis, Systemic Lupus Erythematosus, and Behçet Disease: A Systematic Review. [PDF]

Open Access Rheumatol
Drakopoulos M, Sikora HF, Fahey JD, Mirza RG.   +3 more
europepmc   +1 more source

GNS561 (ezurpimtrostat), a small basic lipophilic molecule, prevents lupus phenotype in a pristane‐induced lupus mouse model

British Journal of Pharmacology, EarlyView.
Background and Purpose Systemic lupus erythematosus is an autoimmune, multisystemic disease affecting all organs in the body. Accrued evidence has elucidated a role for autophagy in the onset and severity of systemic lupus erythematosus. The antimalarial drug hydroxychloroquine constitutes the cornerstone of standard of care for systemic lupus ...
Eya Toumi, Eloïne Bestion, Muriel Militello, Hubert Lepidi, Anne Plauzolles, Nathalie Bardin, Daniel Bertin, Laurent Chiche, Jean‐Louis Mege, Philippe Halfon, Soraya Mezouar   +10 more
wiley   +1 more source

Assessment of retinal microvascular changes in patients with systemic lupus erythematosus using optical coherence tomography angiography. [PDF]

Int J Retina Vitreous
Basiony AI, Elgouhary SM, Mohamed HE, Zahran ES.   +3 more
europepmc   +1 more source

Psychedelics, entactogens and psychoplastogens for depression and related disorders

British Journal of Pharmacology, EarlyView.
Currently, the most actively investigated rapidly acting antidepressants, anxiolytics and/or anti PTSD agents, include psychedelics e.g. psilocybin, LSD, N,N‐dimethyltryptamine, ayahuasca; non‐hallucinogenic entactogens, e.g. MDMA; psychoplastogens which rapidly promote neuroplasticity, e.g.
Daniel Hoyer
wiley   +1 more source